Skip to main content

Advertisement

SpringerLink
Log in

The prognostic value of myocardial perfusion scintigraphy: investigators, are you (mis)leading us?

  • Editorial
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mandalapu BP, Amato M, Stratmann HG. Technetium Tc 99m sestamibi myocardial perfusion imaging. Current role for the evaluation of prognosis [review]. Chest 1999; 115:1684–1694.

    Article  PubMed  CAS  Google Scholar 

  2. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging [review]. J Am Coll Cardiol 1998; 32:57–62.

    Article  PubMed  CAS  Google Scholar 

  3. Hachamovitch R. Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97:535–543.

    Article  PubMed  CAS  Google Scholar 

  4. Underwood SR, Godman B, Salyani S, Ogle JR, Ell PJ. Economics of myocardial perfusion imaging in Europe — The EMPIRE study. Eur Heart J 1999; 20:157–166.

    Article  PubMed  CAS  Google Scholar 

  5. Borm JJJ, Bouwsma H, America YGCJ, van der Wall EE, Pauwels EKJ. Common deficiencies in reporting prognostic data on myocardial perfusion scintigraphy. Eur J Nucl Med 2000; 27:932.

    Google Scholar 

  6. Borm JJJ, America YGCJ, van der Wall EE, Pauwels EKJ. The methodology of follow-up studies for myocardial perfusion imaging affects outcome results. Eur J Nucl Med 2000; 27:1027.

    Google Scholar 

  7. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research. Time for a reassessment? J Am Coll Cardiol 1999; 34:618–620.

    Article  PubMed  CAS  Google Scholar 

  8. Miettinen OS. Theoretical epidemiology. Principles of occurrence research in medicine. New York: John Wiley; 1985:114–116.

    Google Scholar 

  9. Kahn HA, Sempos CT. Statistical methods in epidemiology. Oxford: Oxford University Press, 1989:235–239.

    Google Scholar 

  10. Gunning MG, Anagnostopoulos C, Knight CJ, et al. Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998; 98:1869–1874.

    Article  PubMed  CAS  Google Scholar 

  11. Anonymous. 1996 World Health Statistics Annual. World Health Organization 1998:XXVI.

    Google Scholar 

  12. Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain. Am J Cardiol 1996; 77:1057–1061.

    Article  PubMed  CAS  Google Scholar 

  13. Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress technetium-99 sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol 1996; 28:447–454.

    Article  PubMed  CAS  Google Scholar 

  14. Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994; 89:615–622.

    Article  PubMed  CAS  Google Scholar 

  15. Zanco P, Zampiero A, Favero A, et al. Myocardial technetium-99m sestamibi single-photon emission tomography as a prognostic tool in coronary artery disease: multivariate analysis in a long-term prospective study. Eur J Nucl Med 1995; 22:1023–1028.

    Article  PubMed  CAS  Google Scholar 

  16. Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Circulation 1997; 96:137–147.

    Article  PubMed  CAS  Google Scholar 

  17. Miller DD, Stratmann HG, Shaw L, et al. Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events. J Nucl Cardiol 1994; 1:172–182.

    Article  Google Scholar 

  18. Chatziionnaou SN, Moore WH, Ford PV, et al. Prognostic value of myocardial perfusion imaging in patients with high exercise tolerance. Circulation 1999; 99:867–872.

    Article  Google Scholar 

  19. van Daele MERM, McNeill AJ, Fioretti PM, et al. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction J Am Soc Echocardiogr 1994; 7:370–380. a7i]20._Stratmann HG, Tamesis BR, Younis LT, et al. Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina. Am Heart J 1995; 130:734–740.

    Article  PubMed  Google Scholar 

  20. Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Exercise technetium-99m sestamibi myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol 1995; 76:236–240.

    Article  PubMed  CAS  Google Scholar 

  21. Travin MI, Duca MD, Kline GM, et al. Relation of gender to physician use of test results and to the prognostic value of stress technetium-99m sestamibi myocardial SPECT scintigraphy. Am Heart J 1997; 134:73–82.

    Article  PubMed  CAS  Google Scholar 

  22. Boyne T, Koplan B, Parsons W, et al. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol 1997; 79:270–274.

    Article  PubMed  CAS  Google Scholar 

  23. Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events. Am Heart J 1995; 131:923–929.

    Article  Google Scholar 

  24. Soman P, Pasons A, Lahiri N, Lahiri A. The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol 1999; 6:252–256.

    Article  PubMed  CAS  Google Scholar 

  25. Zanco P, Zampiero A, Favero A, et al. Prognostic evaluation of patients after myocardial infarction: incremental value of sestamibi single-photon emission computed tomography and echocardiography. J Nucl Cardiol 1997; 4:117–124.

    Article  PubMed  CAS  Google Scholar 

  26. Stratmann HG, Mark AL, Amato M, Wittry MD, Younis LT. Risk stratification with pre-hospital discharge exercise technetium-99m sestamibi myocardial tomography in men after acute myocardial infarction. Am Heart J 1998; 136:87–93.

    Article  PubMed  CAS  Google Scholar 

  27. Kastrati A, Schomig A, Elezi S, et al. Prognostic value of the modified American College of Cardiology/American Heart Association stenosis morphology classification for long term angiographic and clinical outcome after coronary stent placement. Circulation 1999; 100:1285–1290.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Division of Nuclear Medicine, Leiden University Medical Center (LUMC), C4-Q, P.O. Box 9600, 2300 RC, Leiden, The Netherlands

    Judocus J. J. Borm, Hanneke Bouwsma & Ernest K. J. Pauwels

  2. Department of Cardiology, Leiden University Medical Center (LUMC), Leiden, The Netherlands

    Ernst E. van der Wall

Authors
  1. Judocus J. J. Borm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanneke Bouwsma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ernst E. van der Wall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ernest K. J. Pauwels
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borm, J.J.J., Bouwsma, H., van der Wall, E.E. et al. The prognostic value of myocardial perfusion scintigraphy: investigators, are you (mis)leading us?. Eur J Nucl Med 28, 1439–1446 (2001). https://doi.org/10.1007/s002590100606

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590100606

Search

Navigation